Home > Healthcare > Drug Device Combination > Therapeutic Systems > Amniotic Membrane Market

Amniotic Membrane Market Share

Report ID: GMI8336
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Amniotic Membrane Market Share

The market is competitive, with a mix of major global and smaller to medium-sized companies vying for market share. Prominent players in the market include MiMedx Group, Inc., Smith & Nephew plc, Integra LifeSciences Holdings Corporation, and Organogenesis Holdings Inc. These leading companies employ various strategies to maintain competitive advantages, including strategic collaborations, partnerships, and mergers, allowing them to capture the highest market share and outperform the competition.

Amniotic Membrane Market Companies

Some of the eminent market participants operating in the amniotic membrane industry include:

Amnio Technology, LLC
Applied Biologics LLC
BioTissue Holdings Inc.
Celularity Inc.
Corza Health, Inc.
Integra LifeSciences Holdings Corporation
MiMedx Group, Inc.
Organogenesis Holdings Inc.
Skye Biologics, Inc.
Smith & Nephew plc

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The industry was valued at approximately USD 1.7 billion in 2023 and is estimated to grow at a 7.9% CAGR from 2024 to 2032, driven by its regenerative properties and applications in medical treatments and surgeries.

The cryopreserved segment is forecasted to reach USD 1.7 billion by 2032 due to its extensive use in various medical disciplines, such as ophthalmology, where it treats corneal defects, promotes faster healing, and reduces inflammation and scarring.

The U.S. market is projected to reach USD 1.1 billion by 2032, driven by well-established healthcare facilities, leading industry players, a focus on regenerative medicine, and the rapid adoption of advanced technologies.

Prominent participants include Amnio Technology, LLC, Applied Biologics LLC, BioTissue Holdings Inc., Celularity Inc., Corza Health, Inc., Integra LifeSciences Holdings Corporation, MiMedx Group, Inc., Organogenesis Holdings Inc., Skye Biologics, Inc., and Smith & Nephew plc.